We found that in the tumor tissue Follistatin and Angiopoietin-2 are differentially expressed between the two tumor types with significantly higher median tissue levels of the two angiogenic factors in SCC patients when compared to AEG patients. The gene discussed is FST; the disease is neoplasm.